https://adjuvantcapital.com/news/ 2026-03-10T14:59:28+00:00 https://adjuvantcapital.com/news/1300/ 2021-02-24T20:41:54+00:00 https://adjuvantcapital.com/news/adjuvant-capital-raises-300-million-global-health-venture-fund/ 2021-02-24T20:43:10+00:00 https://adjuvantcapital.com/news/vc-style-returns-on-unsexy-public-health-bets-gates-backed-adjuvant-capital-gathers-300m-to-mend-a-failure-of-imagination/ 2021-02-24T20:43:16+00:00 https://adjuvantcapital.com/news/gates-merck-and-novartis-backed-adjuvant-capital-raises-300m-for-neglected-diseases/ 2021-02-24T20:43:23+00:00 https://adjuvantcapital.com/news/public-health-focused-adjuvant-capital-backed-by-merck-gates-raises-300m/ 2021-02-24T20:43:29+00:00 https://adjuvantcapital.com/news/investors-put-300-million-into-adjuvant-capital-as-global-health-innovation-shines/ 2021-02-24T20:43:35+00:00 https://adjuvantcapital.com/news/new-300-million-venture-fund-spotlights-role-of-women-in-venture-capital-and-public-health/ 2021-02-24T20:43:44+00:00 https://adjuvantcapital.com/news/investment-firm-raises-300m-to-fund-medical-research-for-overlooked-diseases/ 2021-02-24T20:43:49+00:00 https://adjuvantcapital.com/news/codagenix-serum-institute-to-begin-uk-trials-of-nasal-covid-19-vaccine-in-january/ 2021-02-24T20:46:31+00:00 https://adjuvantcapital.com/news/evofem-biosciences-secures-25-million-strategic-investment-from-adjuvant-capital/ 2021-02-24T20:47:02+00:00 https://adjuvantcapital.com/news/indias-serum-institute-starts-manufacturing-codagenixs-potential-covid-19-vaccine/ 2021-02-24T20:47:41+00:00 https://adjuvantcapital.com/news/merck-covid-19-vaccine-begins-human-testing/ 2021-02-24T20:49:13+00:00 https://adjuvantcapital.com/news/synthetic-biologists-have-created-a-slow-growing-version-of-the-coronavirus-to-give-as-a-vaccine/ 2021-02-24T20:49:41+00:00 https://adjuvantcapital.com/news/african-genomics-startup-554gene-raises-15m-led-by-adjuvant-capital/ 2021-02-24T20:50:10+00:00 https://adjuvantcapital.com/news/to-accelerate-innovation-the-cdc-should-ease-limits-on-which-labs-can-handle-the-coronavirus/ 2021-02-24T20:51:14+00:00 https://adjuvantcapital.com/news/54gene-closes-15m-series-a/ 2021-02-24T20:51:53+00:00 https://adjuvantcapital.com/news/a-new-front-for-nationalism-the-global-battle-against-a-virus/ 2021-02-24T20:52:25+00:00 https://adjuvantcapital.com/news/private-equity-firms-go-after-covid-19-repurposing-portfolio-company-resources/ 2021-02-24T20:54:29+00:00 https://adjuvantcapital.com/news/venture-capitalists-shun-unprofitable-yet-world-saving-vaccines/ 2021-02-24T20:55:49+00:00 https://adjuvantcapital.com/news/codagenix-and-serum-institute-of-india-initiate-co-development-of-a-scalable-live-attenuated-vaccine-against-the-2019-novel-coronavirus-covid-19/ 2021-02-24T20:56:15+00:00 https://adjuvantcapital.com/news/gates-vets-at-adjuvant-back-codagenixs-software-driven-approach-to-recoding-rsv-fly-oncolytic-viruses-and-more/ 2021-02-24T21:46:17+00:00 https://adjuvantcapital.com/news/codagenix-raises-20-million-for-a-new-flu-vaccine-and-other-therapies/ 2021-02-24T21:49:23+00:00 https://adjuvantcapital.com/news/an2-therapeutics-raises-12m-in-series-a-funding/ 2021-02-24T22:22:38+00:00 https://adjuvantcapital.com/news/an2-therapeutics-launches-with-12-million-in-series-a-funding-and-announces-a-strategic-partnership-with-brii-biosciences/ 2021-02-24T22:23:02+00:00 https://adjuvantcapital.com/news/financing-global-health/ 2021-02-24T22:23:26+00:00 https://adjuvantcapital.com/news/themis-raises-e40m-to-run-phase-3-chikungunya-vaccine-trial/ 2021-02-24T22:24:52+00:00 https://adjuvantcapital.com/news/indevr-raises-7-million-in-series-a-financing-with-adjuvant-capital/ 2021-02-24T22:25:15+00:00 https://adjuvantcapital.com/news/south-florida-biotech-raises-56m-in-series-a-funding/ 2021-02-24T22:26:01+00:00 https://adjuvantcapital.com/news/2021-02-24-six-years-separated-from-a-rabies-vaccine-scandal-chinas-yishengbio-grabs-130m-to-go-big-in-infectious-diseases-cancer/ 2021-02-24T22:27:56+00:00 https://adjuvantcapital.com/news/2021-02-24-bringing-the-vc-approach-to-global-health/ 2021-02-25T14:17:27+00:00 https://adjuvantcapital.com/news/2021-05-15-the-full-ratchet-podcast-the-future-of-public-health/ 2021-05-27T18:51:24+00:00 https://adjuvantcapital.com/news/a-small-seattle-biotech-wants-to-take-on-glaxosmithklines-emerging-shingrix-blockbuster/ 2022-02-15T14:53:38+00:00 https://adjuvantcapital.com/news/african-genomics-startup-54gene-raises-25m-to-expand-precision-medicine-capabilities/ 2022-02-15T14:53:54+00:00 https://adjuvantcapital.com/news/2022-01-27-moderna-excision-each-enter-hiv-battle-with-mrna-and-crispr-tech/ 2022-02-15T14:59:57+00:00 https://adjuvantcapital.com/news/2021-11-02-global-vision-for-womens-health-lands-peninsula-biotech-31m/ 2022-02-15T15:05:21+00:00 https://adjuvantcapital.com/news/2022-02-07-univercells-campus-in-jumet-ready-to-produce-vaccines/ 2022-02-15T15:11:29+00:00 https://adjuvantcapital.com/news/2021-12-20-the-gates-foundation-brings-new-funding-to-univercells/ 2022-02-15T15:16:21+00:00 https://adjuvantcapital.com/news/2021-06-10-covid-led-to-a-record-year-for-funding-infectious-disease-companies-will-that-continue/ 2022-02-15T15:20:36+00:00 https://adjuvantcapital.com/news/2023-10-09-antimicrobial-resistance-biotech-secures-37m-with-ex-curevac-ceo-franz-werner-haas-at-the-helm/ 2023-10-23T22:22:14+00:00 https://adjuvantcapital.com/news/2023-10-09-gates-foundation-spends-40m-to-boost-mrna-vaccine-production-in-africa-and-beyond/ 2023-10-24T15:30:59+00:00 https://adjuvantcapital.com/news/2023-10-11-pharma-backed-minervax-raises-e54m-as-it-aims-to-move-its-group-b-streptococcus-vaccine-into-phiii/ 2023-10-24T15:31:47+00:00 https://adjuvantcapital.com/news/biden-administration-awards-500m-for-new-covid-treatments/ 2023-11-01T22:05:30+00:00 https://adjuvantcapital.com/news/2024-11-18-operating-principles-for-impact-management-2024-disclosure-statement/ 2024-11-18T22:06:07+00:00 https://adjuvantcapital.com/news/2023-11-16-adjuvant-capital-opim-disclosure-statement/ 2025-01-05T20:43:31+00:00 https://adjuvantcapital.com/news/2024-05-07-memo-therapeutics-raises-chf-20m/ 2025-02-24T21:38:29+00:00 https://adjuvantcapital.com/news/2025-03-11-adjuvant-capital-included-in-impactassets-50-list-for-2025/ 2025-03-11T19:51:56+00:00 https://adjuvantcapital.com/news/2025-09-30-operating-principles-for-impact-management-2025-disclosure-statement/ 2025-10-11T20:40:10+00:00 https://adjuvantcapital.com/news/2025-10-11-impact-report-from-adjuvant-capital/ 2025-10-11T20:44:05+00:00 https://adjuvantcapital.com/news/2026-03-10-adjuvant-capital-included-in-impactassets-50-list-for-2026/ 2026-03-10T14:59:28+00:00